Abstracts
British Association for the Study of the Liver Meeting
| The first 150 words of the full text of this article appear below. |
The following abstracts were presented at the British Association for the Study of the Liver Meeting, University of Southampton, UK, September 7-8, 2000.
N. Mellor1, M. Themis2, C. Selden1, M. Jones3, H. J. F. Hodgson1. 1 Centre for Hepatology, Royal Free Campus-UCL, Rowland Hill St., London, NW3 2PF.2 Cystic Fibrosis Gene Therapy Research Group, Imperial College School of Medicine, London. 3 Dept of Infectious Diseases, Imperial College School of Medicine, London. n.mellor@rfc.ucl.ac.uk
Introduction: Histidinaemia is an autosomal recessive disorder in man affecting the hepatic enzyme histidase resulting in elevated plasma and urinary histidine. A mouse model with a similar phenotype lends itself to investigating methods of gene therapy.
Aim: To revert the biochemical phenotype in by in vivo retroviral gene transfer.
Methods: A cDNA encoding normal histidase was cloned into the LNCX retroviral construct under the control of the CMV promoter. Virus was concentrated and administered to histidinaemic mice primed for hepatocyte transfection by partial hepatectomy. HPLC flow scintillation was used to assess in vivo catalysis of 14C-histidine. Hepatic cytosol was examined for histidase expression by Western analysis and enzyme activity by conversion of histidine to urocanic acid.
Results: Infected animals showed a
33%±15% enhancement of metabolism as shown
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
